Princeton West Innovation Center, NJ USA
Our flagship U.S. biologics manufacturing and clinical R&D facility at the Princeton West Innovation Campus in Hopewell, N.J., spans 42 acres and represents an $800 million capital investment. This state-of-the-art facility, with 150,000 sq ft of space and a total of 8,000L cell culture capacity, supports both clinical- and commercial-stage biologics manufacturing, as well as clinical R&D capabilities, further complementing BeiGene’s existing global network and enhancing our ability to deliver innovative therapies worldwide.
